Reexamining the Value of Procalcitonin
Healthcare organizations face a constant tension between driving antimicrobial stewardship and managing tight operational budgets. With antimicrobial resistance (AMR) tied to 2.8 million infections in the US each year, stewardship is a critical priority.1 Yet broad-spectrum antibiotics are routinely initiated before diagnostic results are available, increasing treatment duration and exposure. While procalcitonin (PCT) testing is […] The post Reexamining the Value of Procalcitonin appeared...
Original Source
Read the full article at Beckershospitalreview →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.